Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zengerle

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ACS Chemical Biology|June 3, 2015
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4Michael Zengerle, Kwok-Ho Chan, Alessio Ciulli
Journal of Medicinal Chemistry|June 9, 2017
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor ScaffoldsKwok-Ho Chan, Michael Zengerle, Andrea Testa, et al.
Toxicology Letters|November 5, 2013
Detoxification of alkyl methylphosphonofluoridates by an oxime-substituted β-cyclodextrin--an in vitro structure-activity studyAnne Bierwisch, Michael Zengerle, Horst Thiermann, et al.
Current Opinion in Chemical Biology|July 17, 2016
Chemical genetics approaches for selective intervention in epigeneticsAndrew C Runcie, Kwok-Ho Chan, Michael Zengerle, et al.
Toxicology Letters|February 25, 2014
Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivoFranz Worek, Thomas Seeger, Michael Zengerle, et al.
Beilstein Journal of Organic Chemistry|January 13, 2012
Highly efficient cyclosarin degradation mediated by a β-cyclodextrin derivative containing an oxime-derived substituentMichael Zengerle, Florian Brandhuber, Christian Schneider, et al.
Journal of Medicinal Chemistry|September 15, 2015
New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain InhibitionMatthias G J Baud, Enrique Lin-Shiao, Michael Zengerle, et al.
Chemical Communications (Cambridge, England)|March 19, 2013
Tabun scavengers based on hydroxamic acid containing cyclodextrinsFlorian Brandhuber, Michael Zengerle, Luzian Porwol, et al.
Toxicology|September 18, 2012
Detoxification of tabun at physiological pH mediated by substituted β-cyclodextrin and glucose derivatives containing oxime groupsFlorian Brandhuber, Michael Zengerle, Luzian Porwol, et al.
Nature Chemical Biology|March 14, 2017
Structural basis of PROTAC cooperative recognition for selective protein degradationMorgan S Gadd, Andrea Testa, Xavier Lucas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|June 3, 2015
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4Michael Zengerle, Kwok-Ho Chan, Alessio Ciulli
Journal of Medicinal Chemistry|June 9, 2017
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor ScaffoldsKwok-Ho Chan, Michael Zengerle, Andrea Testa, et al.
Toxicology Letters|November 5, 2013
Detoxification of alkyl methylphosphonofluoridates by an oxime-substituted β-cyclodextrin--an in vitro structure-activity studyAnne Bierwisch, Michael Zengerle, Horst Thiermann, et al.
Current Opinion in Chemical Biology|July 17, 2016
Chemical genetics approaches for selective intervention in epigeneticsAndrew C Runcie, Kwok-Ho Chan, Michael Zengerle, et al.
Toxicology Letters|February 25, 2014
Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivoFranz Worek, Thomas Seeger, Michael Zengerle, et al.
Beilstein Journal of Organic Chemistry|January 13, 2012
Highly efficient cyclosarin degradation mediated by a β-cyclodextrin derivative containing an oxime-derived substituentMichael Zengerle, Florian Brandhuber, Christian Schneider, et al.
Journal of Medicinal Chemistry|September 15, 2015
New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain InhibitionMatthias G J Baud, Enrique Lin-Shiao, Michael Zengerle, et al.
Chemical Communications (Cambridge, England)|March 19, 2013
Tabun scavengers based on hydroxamic acid containing cyclodextrinsFlorian Brandhuber, Michael Zengerle, Luzian Porwol, et al.
Toxicology|September 18, 2012
Detoxification of tabun at physiological pH mediated by substituted β-cyclodextrin and glucose derivatives containing oxime groupsFlorian Brandhuber, Michael Zengerle, Luzian Porwol, et al.
Nature Chemical Biology|March 14, 2017
Structural basis of PROTAC cooperative recognition for selective protein degradationMorgan S Gadd, Andrea Testa, Xavier Lucas, et al.
Pageof 2